CompletedPhase 2NCT01689727

Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Pituitary Tumors

Studying Pituitary tumor

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Endocyte
Principal Investigator
Nelson Oyesiku, MD, M.D
Emory Hospital
Intervention
Technetium Tc 99m EC20(drug)
Enrollment
40 target
Eligibility
18 years · All sexes
Timeline
2002

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01689727 on ClinicalTrials.gov

Other trials for Pituitary tumor

Additional recruiting or active studies for the same condition.

See all trials for Pituitary tumor

← Back to all trials